At a glance
- Originator Aventis
- Class Antihypertensives
- Mechanism of Action Dopamine beta hydroxylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 22 Dec 2003 Discontinued - Preclinical for Hypertension in USA (unspecified route)